4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-25-084492
Chief Scientific Officer acquired 48,978 shares (conversion)
- Chief Scientific Officer returned 48,978 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reich Kristian Chief Scientific Officer | 2025-09-02 | Conversion | +48,978 | 202,908 | D | ||
| Reich Kristian Chief Scientific Officer | 2025-09-02 | Returned to the company | −48,978 | 35,389 | D | ||
| Derivatives | |||||||
| Reich Kristian Chief Scientific Officer | 2025-01-20 | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −1,456 | 1,052 | D | ||
Loading xslF345X05/ownership.xml…